Kelyniam Global Q1 FY26 operating income turns positive to 295,295; revenue rises 84% to 1.15 million
KELYNIAM GLOBAL INC
KELYNIAM GLOBAL INC KLYG | 0.00 |
- Kelyniam Global reported Q1 results with revenue up 84% to $1,150,130 year over year.
- Gross profit more than doubled to $962,814, rising 105%.
- Operating results turned to income of $295,295 from an operating loss.
- Sales of CustomizedBone implants climbed more than 50% year over year, while a one-time consulting and development agreement contribution boosted quarterly revenue.
- CEO Ross Bjella said results reflect growing demand for regenerative products, while Kelyniam completed first Fusion PEEK + Bicalcium Phosphate implant and holds exclusive U.S. marketing rights through March 2028.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kelyniam Global Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605110001PR_NEWS_USPR_____NY55720) on May 11, 2026, and is solely responsible for the information contained therein.
